Regen Biopharma (RGBP.OTC) gets 180% bump for cancer-fighting patent
We all know someone who's been touched by cancer. It's been called the worst scourge of civilized mankind. It sweeps through a family, disrupting our...
Category: BioTech
GW Pharma (GWPH.Q) gets recommendation on cannabis-derived epilepsy drug
GW Pharmaceuticals (GWPH.Q) has received a recommendation from the European Medicines Agency (EMA) for the authorization of the company's Epidyolex cannabis...
ProMis Neurosciences (PMN.T) and the fight against Alzheimer’s
Someone in the world develops dementia every three seconds. Alzheimer's disease and other dementia-related disorders affect 50M people around the world and...
Stellar Biotechnologies (SBOT.Q) stock jumps 78% on news of successful acquisition
According to the World Health Organization, around 50 million people suffer from dementia worldwide and nearly 10 million new cases are diagnosed every year....
Emerald Health (EMH.V) director stands down over security clearance issues
Buried in a news release discussing a shares-for-cash payment to an acquisition target, Emerald Health (EMH.V) stated Monday it is losing a board member over...
World Class Extractions (PUMP.C) absorbs Quadron Cannatech (QCC.C)
World Class Extractions (PUMP.C), a newcomer in the extraction sector, signed an LOI to acquire Quadron Cannatech (QCC.C) today. This acquisition will put...
Move over cannabis: biotech bounces back for a bullish 2019
Cannabis went crazy in 2018. Billion-dollar acquisitions by international food and beverage giants like Constellation Brands (STZ.NYSE) as well as Canada...
The opportunity in cannabis’ supporting players
What makes this cannabis market really exciting is that it's largely uncharted territory. When cannabis went live last October, it opened the door for...
Equity.Guru Podcast: Titan Pharmaceuticals (TTNP.NASDAQ)
Titan Pharmaceuticals (TTNP.Q) is an American pharmaceutical company based out of San Francisco, California. The company has recently relaunched Probuphine,...
Vitalhub (VHI.V) shows up strong for 2019, but has the market moved on?
Vitalhub (VHI.V) has come out strong in the first two weeks of 2019 showing a solid trajectory for the company's direction in spite of a market which has shown...
Merry Christmas from a hospital in China
by Guy Bennett Christmas Eve, 2018 – I’m writing this from a hospital bed in a hard scrabble town in the mountains of Yunnan Province, China, called...
Three non-weed deals you don’t know: ParcelPal (PKG.C), Clear Blue (CBLU.V), and Titan Medical (TMD.T)
If I was getting paid by the number of pitches I hear, I'd be making a lot more money than I do. Often, they're terrible. And I include 'just okay' in the...
Stony Hill (STNY:OTC) adds to advisory board as advisor-linked company makes moves
Sometimes when a public company is being quiet, the only way to figure out what they're up to is to connect dots and assess risk. Stony Hill Corporation...
Helius Medical Technologies (HSM.T): The market doesn’t get it. We think we do
A few years back, I wrote about Helius Medical Technologies (HSM.T), which I heard about from Fabrice Taylor, and liked a lot as a long term biotech...
Everyone’s a genius when the market is on a run: HIVE, TNY, DOJA, CYX, QMC, oh my!
I've noticed a subtle change in the order of things lately that, while it may seem a small thing, it's actually a sign of something much bigger. Normally, I...
